-transparent.png){kind=logo}
N-acetylglucosaminyl-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP), a new liposome-encapsulated muramyl dipeptide analog, was studied for its effect on the Lewis lung carcinoma metastatic spreading as well as on the adenosine deaminase (ADA) and 5'-nucleotidase (5-N) activity in the alveolar and peritoneal mice macrophages. The drug administration was found to cause a sharp dose-dependent decrease in the lung metastases volume and number as compared to those in mice not treated with GMDP. The antimetastatic effect of GMDP is accompanied by an increase in the functional macrophage activity determined by ADA and 5-N level in these cells.
Related Publications
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
July 1983,
International journal of cancer,
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
January 1987,
Eksperimental'naia onkologiia,
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
July 1987,
Cancer research,
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
March 1986,
Cancer research,
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
March 1986,
Cancer research,
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
November 1983,
Cancer research,
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
January 1992,
Pharmacological research,
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
April 2014,
Journal of applied toxicology : JAT,
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
January 1989,
Oncology,
V Iu Umanskiĭ, and
A V Stefanov, and
O P Bondar', and
S A Braginskiĭ, and
K P Balitskiĭ
October 2023,
Experimental oncology,
